Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (7713)	5/4/1998 6:57:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

Eye Doctors Caution Viagra Users: Newly-approved Drug May Cause Visual Side Effects SAN FRANCISCO, May 4 /PRNewswire/ -- Today, doctors at the American Academy of Ophthalmology, the world's largest organization of eye physicians and surgeons, warned users of the newly-approved anti-impotence drug, Viagra, about the potential side effects that may affect vision. Michael F. Marmor, MD, Professor of Ophthalmology at Stanford University and spokesperson for the Academy, said that a moderate percentage of people taking Viagra have experienced problems with their vision. ''FDA clinical trials show that taking the medication, especially at higher doses, can cause some retinal dysfunction and affect the way we see for a number of hours.'' Patients reported visual disturbances described as bluish color tinge and light sensitivity. Dr. Marmor said a clinical study showed that electrical measures of retinal function dropped by 30 to 50 percent and lasted for at least five hours after taking a high dose of Viagra. ''On the surface, seeing the world with a bluish tinge may just be annoying,'' Dr. Marmor said. It is not known, however, whether or not the drug causes any permanent changes in vision. ''We need to do some studies about the long-term effects of taking Viagra.'' In the meantime, Dr. Marmor urged those with retinal eye conditions such as macular degeneration or retinitis pigmentosa to use the drug with caution. ''Stay at the lowest dose level possible,'' he said. According to the FDA, the recommended dose level for most patients is 50 mg. The American Academy of Ophthalmology is the world's largest organization of eye physicians and surgeons (Eye M.D.s), with more than 23,000 members. The mission of the Academy is to achieve accessible, appropriate and affordable eye care for the public by serving the educational and professional needs of ophthalmologists. Visit the Academy's website at www.eyenet.org. SOURCE: American Academy of Ophthalmology

To: Bradpalm1 who wrote (7713)	5/4/1998 7:55:00 PM
From: AlienTech	Read Replies (2) \| Respond to of 23519

>>Last Friday, a Vivus 'Primary Care Consultant' detailed our office for the very first time. Her presentation was very professional and she answered questions about Muse, Viagra and other ED alternatives very honestly and directly.<< Just for my own info.. Are there a lot of sales women doing this? I guess a 'Primary Care Consultant' is a sales rep? I can see professionalism but how can she be honest about some of the answers? Men react differently to some things, like hey bud you need to stick this thing up your pecker well, I dont think a woman can know the feeling. And you said she was honest about the different ed alternatives, care to give us a brief synopsis on what she said? And these sales rep's dont directly work for vivus right? >>a reprint about Erectile Dysfunction from Patient Care (PCP throw away journal), << I suppose this is an old and outdated publication?

To: Bradpalm1 who wrote (7713)	5/4/1998 9:40:00 PM
From: JFD	Respond to of 23519

This might have been a wasted effort 6-8 months ago. People would have forgotten their presentation with the viagra hoopla. they are striking while the ed iron is hot. In the past you have been justly critical of vvus and muse. This objective report from you is encouraging. Thanks for the info. jfd